Year: 2014
Type: article
Abstract: HLA-matched sibling donors (MSDs) have long been the gold standard for allogeneic blood or marrow transplantation (alloBMT), but only about 35% of patients have an HLA-matched sibling [1]. The use of HLA-matched unrelated donors (MUDs; and their accompanying donor registries) widened the donor pool, but alloBMT was still unavailable to many individuals, particularly those in need of rapid transplantation for advanced diseases or those belonging to many minority groups. Other alternative donor transplantation approaches, including umbilical cord blood transplantation (UCBT) and modern approaches to HLA-haploidentical (haplo) alloBMT, have made donors available to nearly all patients who might require alloBMT [2-5].
Authors: Christopher G. Kanakry, Leo Luznik
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W1968872381
